Ekf Diagnostics Plc logo

Ekf Diagnostics Plc(LSE) EKF

Market Cap£103.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)-21%
5 Year-70%
1 Year-20%
1 Month-5%
£0.24
-0.42%
-0.00Today
Ekf Diagnostics Plc last closing stock price
MetricPriceDate
Last closeGBX 24.002026-10-06
Ekf Diagnostics Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.61%GBX 24.902026-09-29
1 month-4.95%GBX 25.252026-09-04
3 month-7.34%GBX 25.902026-07-08
Year to date-9.09%GBX 26.402025-12-31
1 year-20.27%GBX 30.102025-10-06
3 year-11.11%GBX 27.002023-10-06
5 year-69.62%GBX 79.002021-10-07
Since inception-21.03%GBX 0.312002-06-05

Ekf Diagnostics Plc Financials at a Glance

Market Cap

£103.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£101.58M

Net Income (TTM)

£8.62M

EPS (TTM)

£0.01

P/E Ratio

41.55

Dividend

£0.00

Beta (Volatility)

0.02 (Low)

Price

£0.24

Volume

82,115

Open

£0.24

Previous Close

£0.24

Daily Range

£0.24 - £0.25

52-Week Range

£0.22 - £0.31

Estimated Earnings Date

N/A

EKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ekf Diagnostics Plc

EKF Diagnostics Holdings plc is an international supplier of diagnostic solutions, specializing in the development, manufacturing, and distribution of diagnostic instruments and chemical reagents. Founded in 1990 and based in Cardiff, the company serves a diverse global market, addressing critical diagnostic needs across various healthcare sectors.

Products and Services
  • Hemoglobin analysis devices, including DiaSpect Tm and Hemo Control
  • Advanced glucose and lactate analyzers like the Biosen C-Line series
  • Point-of-care solutions for diabetes management, such as Quo-Lab A1c
Growth Outlook
  • Revenue of £25.03 million reported in Q2 2026, indicating stable performance
  • Net income of £2.32 million in Q2 2026, reflecting profitability
  • Strong cash flow with £3.32 million from operating activities in Q2 2026
Financial Highlights
  • Gross profit margin of 53.03% in Q2 2026, showcasing operational efficiency
  • Current ratio of 4.72, indicating strong liquidity position
  • Net income margin of 9.27% in Q2 2026, demonstrating effective cost management
EKF Diagnostics Holdings plc has established itself as a key player in the medical devices industry, with a robust product portfolio that meets various diagnostic needs. The company's recent financial performance highlights its ability to generate consistent revenue and maintain profitability, supported by a strong liquidity position. The growth outlook remains positive, driven by ongoing demand for diagnostic solutions across global markets. With a focus on innovation and quality, EKF Diagnostics is well-positioned to capitalize on emerging opportunities in the healthcare sector.
AI Generated • Sep 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

301

CEO

Gavin Joseph Jones

Website

www.ekfdiagnostics.com

Headquarters

Cardiff, CF64 2EZ, GB

EKF Financials

Key Financial Metrics (TTM)

Gross Margin

52.74%

Operating Margin

13.25%

Net Income Margin

4.86%

Return on Equity

3.58%

Return on Capital

9.91%

Return on Assets

3.03%

Earnings Yield

2.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£103.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

427.97M

Volume

82.11K

Avg. Volume

425.08K

Financials (TTM)

Gross Profit

£52.09M

Operating Income

£13.71M

EBITDA

£23.76M

Operating Cash Flow

£18.82M

Capital Expenditure

-£3.15M

Free Cash Flow

£15.67M

Cash & ST Invst.

£15.97M

Total Debt

£1.47M

Ekf Diagnostics Plc Performance Analysis

Ekf Diagnostics Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 66,635,000-18.6%
20232023-12-31GBP 52,611,000-21.0%
20242024-12-31GBP 50,194,000-4.6%
20252025-12-31GBP 51,564,0002.7%
Ekf Diagnostics Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-0.9%
Q22025-06-301.0%
Q42025-12-314.3%
Q22026-06-30-4.9%
Ekf Diagnostics Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.02N/A
20232023-12-31GBP 0.01N/A
20242024-12-31GBP 0.01165.4%
20252025-12-31GBP 0.00-65.9%
Ekf Diagnostics Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31100.0%
Q22025-06-30-53.3%
Q42025-12-31-90.7%
Q22026-06-301250.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£25.03M

-0.7%

Gross Profit

£13.27M

+10.0%

Gross Margin

53.03%

N/A

Market Cap

£103.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£334.87K

N/A

Employees

308

N/A

Net Income

£2.32M

+12.3%

EBITDA

£5.82M

+4.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£15.97M

+62.7%

Total Debt

£1.47M

+18.1%

Accounts Receivable

£7.07M

+5.0%

Inventory

£9.14M

+12.0%

Long Term Debt

£1.13M

+12.4%

Short Term Debt

£337.00K

+42.2%

Return on Assets

3.03%

N/A

Return on Invested Capital

9.01%

N/A

Free Cash Flow

£2.45M

-61.5%

Operating Cash Flow

£3.32M

-57.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SCLP.LScancell Holdings plc
£0.09+0.53%
BVXP.LBioventix PLC
£17.25+2.37%
STX.LShield Therapeutics plc
£0.06-5.88%
CREO.LCreo Medical Limited
£0.10+2.51%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$171.92+0.48%
INTCIntel
$112.50-3.18%
NVDANvidia
$239.24+0.14%
NUNu Holdings
$15.66+3.16%

Questions About EKF

What is the current price of Ekf Diagnostics Plc?

Ekf Diagnostics Plc is trading at £0.24 per share.

What is the 52-week range for Ekf Diagnostics Plc?

Over the past 52 weeks, Ekf Diagnostics Plc has traded between £0.22 and £0.31.

How much debt does Ekf Diagnostics Plc have?

As of the most recent reporting period, Ekf Diagnostics Plc reported total debt of £1.39M.

How much cash does Ekf Diagnostics Plc have on hand?

Ekf Diagnostics Plc reported £15.83M in cash and cash equivalents in its most recent financial results.

What is Ekf Diagnostics Plc’s dividend yield?

Ekf Diagnostics Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services